Helen E. Lotery
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helen E. Lotery has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Rudolph P Galask
Departments of Obstetrics and Gynecology, Microbiology, and Dermatology, University of Iowa Hospitals and Clinics, Iowa, USA
2 shared publicationsAdam Haworth
Department of Dermatology, Portsmouth Hospitals Trust, Portsmouth, UK
1 shared publicationAnthony Downs
Department of Dermatology, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK
1 shared publicationChristopher Lovell
Department of Dermatology, Kinghorn Dermatology Unit, Bath, UK
1 shared publicationDavid Orton
Department of Dermatology, Amersham Hospital, Amersham, UK
1 shared publicationDavid Todd
Department of Dermatology, Essex County Hospital, Colchester, UK
1 shared publication
Latest Publications
- 12 July 2007
- Published by Wiley in Contact Dermatitis
- Vol. 57 (3) , 169-172
Dicaprylyl maleate – an emerging cosmetic allergen
Dicaprylyl maleate (DCM) has been reported rarely as a cause of allergic contact dermatitis. The objectives of this study were to identify patients from multiple centres with allergy to DCM in cosmetic products confirmed by patch testing and, in addition, to investigate the effect of testing with aged DCM. This is an international multicentre study of 22 patients with 26 reactions to products containing DCM. Patch testing was carried out to ingredients including DCM obtained from the manufacturer. Further testing was carried out with deliberately aged DCM in a sample of patients. 22 patients had clinical and positive patch test reactions at 4 days to a total of 26 cosmetic products containing DCM. 5 patients did not react to DCM prepared by the manufacturer from concurrent factory stock but did have positive reactions to a deliberately aged batch of DCM. DCM is an emerging cosmetic allergen. Testing with aged material yields a greater number of positive results. Co‐operation between cosmetics manufacturers and clinicians is important in the identification of new allergens.
- 12 July 2007
- Published by Wiley in Contact Dermatitis
- Vol. 57 (3) , 169-172
Dicaprylyl maleate – an emerging cosmetic allergen
Dicaprylyl maleate (DCM) has been reported rarely as a cause of allergic contact dermatitis. The objectives of this study were to identify patients from multiple centres with allergy to DCM in cosmetic products confirmed by patch testing and, in addition, to investigate the effect of testing with aged DCM. This is an international multicentre study of 22 patients with 26 reactions to products containing DCM. Patch testing was carried out to ingredients including DCM obtained from the manufacturer. Further testing was carried out with deliberately aged DCM in a sample of patients. 22 patients had clinical and positive patch test reactions at 4 days to a total of 26 cosmetic products containing DCM. 5 patients did not react to DCM prepared by the manufacturer from concurrent factory stock but did have positive reactions to a deliberately aged batch of DCM. DCM is an emerging cosmetic allergen. Testing with aged material yields a greater number of positive results. Co‐operation between cosmetics manufacturers and clinicians is important in the identification of new allergens.
- 1 September 2003
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 102 (3) , 645
Erosive Lichen Planus of the Vulva and Vagina
- 1 September 2003
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 102 (3) , 645
Erosive Lichen Planus of the Vulva and Vagina
- 1 September 2003
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 102 (3) , 647
Erosive lichen planus of the vulva and vagina: Reply
- 1 September 2003
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 102 (3) , 647
Erosive lichen planus of the vulva and vagina: Reply